Review article : Hypercalcaemia of malignancy
- 1 January 1989
- journal article
- review article
- Published by SAGE Publications in Palliative Medicine
- Vol. 3 (1) , 1-11
- https://doi.org/10.1177/026921638900300102
Abstract
This article reviews the incidence and clinical features of hypercalcaemia caused by malignancy. The pathogenesis is examined, looking at recent evidence on endocrinological processes, particularly parathyroid hormone related protein. Finally the article reviews current thinking on treatment.Keywords
This publication has 51 references indexed in Scilit:
- N-Terminal amino acid sequence of two novel tumor-derived adenylate cyclase-stimulating proteins: Identification of parathyroid hormone-like and parathyroid hormone-unlike domainsBiochemical and Biophysical Research Communications, 1987
- An interleukin 1 like factor stimulates bone resorption in vitroNature, 1983
- Factors associated with humoral hypercalcemia of malignancy stimulate adenylate cyclase in osteoblastic cells.Journal of Clinical Investigation, 1983
- Absence of Parathyroid Hormone Messenger RNA in Nonparathyroid Tumors Associated with HypercalcemiaNew England Journal of Medicine, 1983
- Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease.Proceedings of the National Academy of Sciences, 1982
- VASOPRESSIN FUNCTION IN HYPERCALCAEMIAClinical Endocrinology, 1981
- Biochemical Evaluation of Patients with Cancer-Associated HypercalcemiaNew England Journal of Medicine, 1980
- Epidermal growth factor stimulates prostaglandin production and bone resorption in cultured mouse calvariaBiochemical and Biophysical Research Communications, 1978
- Some thoughts on the nature of ectopic parathyroid hormonesThe American Journal of Medicine, 1971
- Cortisone in the treatment of hypercalcemia in neoplastic diseaseCancer, 1958